✦ LIBER ✦

Immunization against proprotein convertase subtilisin-like/kexin type 9 lowers plasma LDL-cholesterol levels in mice

✍ Scribed by Fattori, E.; Cappelletti, M.; Lo Surdo, P.; Calzetta, A.; Bendtsen, C.; Ni, Y. G.; Pandit, S.; Sitlani, A.; Mesiti, G.; Carfi, A.; Monaci, P.

Book ID: 115476296
Publisher: Lipid Research, Inc.
Year: 2012
Tongue: English
Weight: 857 KB
Volume: 53
Category: Article
ISSN: 0022-2275
DOI: 10.1194/jlr.m028340

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Antisense inhibition of proprotein conve

Antisense inhibition of proprotein convertase subtilisin/kexin type 9 reduces serum LDL in hyperlipidemic mice

✍ Graham, M. J.; Lemonidis, K. M.; Whipple, C. P.; Subramaniam, A.; Monia, B. P.; 📂 Article 📅 2007 🏛 Lipid Research, Inc. 🌐 English ⚖ 225 KB

Serum levels of proprotein convertase su

Serum levels of proprotein convertase subtilisin/kexin type 9 in subjects with familial hypercholesterolemia indicate that proprotein convertase subtilisin/kexin type 9 is cleared from plasma by low-density lipoprotein receptor–independent pathways

✍ Jamie Cameron; Martin P. Bogsrud; Kristian Tveten; Thea Bismo StrØm; Kirsten Hol 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 93 KB

Relationship of plasma apolipoprotein M

Relationship of plasma apolipoprotein M with proprotein convertase subtilisin–kexin type 9 levels in non-diabetic subjects

✍ Paul J.W.H. Kappelle; Gilles Lambert; Björn Dahlbäck; Lars Bo Nielsen; Robin P.F 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 153 KB

Plasma proprotein convertase subtilisin

Plasma proprotein convertase subtilisin kexin type 9 is not altered in subjects with impaired glucose metabolism and type 2 diabetes mellitus, but its relationship with non-HDL cholesterol and apolipoprotein B may be modified by type 2 diabetes mellitus: The CODAM study

✍ M.C.G.J. Brouwers; J.S. Troutt; M.M.J. van Greevenbroek; I. Ferreira; E.J. Feske 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 162 KB